CORI Corium International, Inc.

6.85
-0.02  -0%
Previous Close 6.87
Open 6.25
Price To book 94.11
Market Cap 200.24M
Shares 29,232,000
Volume 1,314,266
Short Ratio 3.26
Av. Daily Volume 155,138

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued 2013. Phase 3 top-line data released January 3, 2017 - poor data but partner Agile Therapeutics intends to reflile NDA by the end of June, 2017.
Twirla
Contraceptive patch
Pilot bioequivalence data due released May 11, 2017. Pivotal trial to commence fall of 2017 with preliminary data due February 2018.
Corplex Donepezil
Alzheimer's disease
Phase 2a data released July 2015
MicroCor PTH
Osteoporosis
Additional Phase 3 required following rejection of NDA. Trial is ongoing by partner Agile
AG200-15
Contraceptive

Latest News

  1. ETFs with exposure to Corium International, Inc. : May 25, 2017
  2. Corium Prices Follow-On Offering of Common Stock
  3. Corium Announces Proposed Public Offering of Common Stock
  4. Corium International, Inc. :CORI-US: Earnings Analysis: Q2, 2017 By the Numbers : May 24, 2017
  5. AxoGen (AXGN) Shows Strength: Stock Adds 6.1% in Session
  6. Edited Transcript of CORI earnings conference call or presentation 11-May-17 12:30pm GMT
  7. Can The Uptrend Continue for Corium International (CORI)?
  8. Corium reports 2Q loss
  9. Corium Reports Positive Preliminary Results in Alzheimer’s Clinical Study
  10. Corium Reports Second Quarter Fiscal 2017 Financial Results and Recent Corporate Highlights
  11. Corium to Report Preliminary Results from Corplex Donepezil Pilot Study and Second Quarter Fiscal 2017 Financial Results Before Market Open on Thursday, May 11, 2017
  12. Shire (SHPG) Beats on Q1 Earnings & Sales, Reiterates View
  13. Anthem (ANTM) to Report Q1 Earnings: A Beat in the Cards?
  14. ETFs with exposure to Corium International, Inc. : April 7, 2017
  15. Corium to Present at the 16th Annual Needham Healthcare Conference
  16. Corium to Participate in BioPharma Dealmakers Webcast on New Innovations in Drug Delivery Technology
  17. Corium International, Inc. :CORI-US: Earnings Analysis: Q1, 2017 By the Numbers : March 20, 2017
  18. Corium Reports Positive Progress in Pilot Bioequivalence Study of Once-Weekly Corplex™ Donepezil Patch
  19. Edited Transcript of CORI earnings conference call or presentation 13-Feb-17 10:00pm GMT